Awen M Gallimore

13PUBLICATIONS
49CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 13, 2026
Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice.

|Feb 02, 2026
Optimizing anti-PI3Kδ and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple-negative breast cancer improves outcome by removing treatment-related adverse events.

Sarah Nicol Lauder, Ana Pires, Michelle Somerville

|Sep 23, 2025
TIM3 is a context-dependent coregulator of cytotoxic T cell function.

Hanin Alamir, Carissa C W Wong, Amal Alsubaiti

|Apr 01, 2022
Tumor-Associated High Endothelial Venules: Inroads Enabling Immune Control of Cancer Progression.

Awen Gallimore

|Mar 10, 2022
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity.

Stephanie E A Burnell, Lorenzo Capitani, Bruce J MacLachlan

|Nov 14, 2021
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers.

Martin J Scurr, Wioleta M Zelek, George Lippiatt

Pageof 3

Frequent Collaborators

5 joint publications

Andrew Godkin

3 joint publications

Bruce J MacLachlan

2 joint publications

Alexander Greenshields-Watson

2 joint publications

Martin J Scurr